p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades

被引:116
作者
Fang, L
Li, GN
Liu, GZ
Lee, SW [1 ]
Aaronson, SA
机构
[1] Harvard Univ, Inst Med, Beth Israel Med Ctr, Dept Med, Boston, MA 02115 USA
[2] Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
Akt; HB-EGF; MAPK; p53; tumor suppressor;
D O I
10.1093/emboj/20.8.1931
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 induction in response to cellular stresses activates the mitogen-activated protein kinase (MAPK) cascade through pathways involving Ras and Raf, p53's ability to activate this pathway is dependent on p53-mediated transcription, In order to investigate potential p53 target gene(s) involved, we utilized expression array analysis and identified heparin-binding epidermal growth factor-like growth factor (HB-EGF) as being markedly up-regulated by p53, In response to DNA damage, HB-EGF was induced in wild-type, but not in mutant p53-containing cells, implying its p53 dependence. HB-EGF neutralizing antibody and inhibitors of EGF receptor signaling abrogated p53-induced MAPK activation. Expression of HB-EGF was shown to protect cells from H2O2-induced apoptosis through MAPK activation. Additionally, the PI3K/Akt pathway was activated in response to p53 signaling through HB-EGF induction, and inhibition of MAPK and Akt activation after DNA damage decreased cell survival in wild-type p53-containing cells. All these findings point to a novel aspect of p53 function. Namely, p53-induced growth factors such as HB-EGF, which activate MAPK and Akt signaling, may be involved in a compensatory mechanism to alleviate adverse effects of cellular stresses.
引用
收藏
页码:1931 / 1939
页数:9
相关论文
共 39 条
  • [1] Attardi LD, 2000, GENE DEV, V14, P704
  • [2] Tyrosine kinase inhibitors .8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor
    Bridges, AJ
    Zhou, H
    Cody, DR
    Rewcastle, GW
    McMichael, A
    Showalter, HDH
    Fry, DW
    Kraker, AJ
    Denny, WA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 267 - 276
  • [3] RADIATION-INDUCED CELL-CYCLE ARREST COMPROMISED BY P21 DEFICIENCY
    BRUGAROLAS, J
    CHANDRASEKARAN, C
    GORDON, JI
    BEACH, D
    JACKS, T
    HANNON, GJ
    [J]. NATURE, 1995, 377 (6549) : 552 - 557
  • [4] Buckley J. S., 1995, SPE ADV TECH SER, V3, P53, DOI [10.2118/26675-PA, DOI 10.2118/26675-PA]
  • [5] Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway
    Cunnick, JM
    Dorsey, JF
    Standley, T
    Turkson, J
    Kraker, AJ
    Fry, DW
    Jove, R
    Wu, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14468 - 14475
  • [6] Cellular survival: a play in three Akts
    Datta, SR
    Brunet, A
    Greenberg, ME
    [J]. GENES & DEVELOPMENT, 1999, 13 (22) : 2905 - 2927
  • [7] DENT P, 1995, MOL CELL BIOL, V15, P4125
  • [8] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [9] Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
    Elenius, K
    Paul, S
    Allison, G
    Sun, J
    Klagsbrun, M
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1268 - 1278
  • [10] p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53
    Fang, L
    Igarashi, M
    Leung, J
    Sugrue, MM
    Lee, SW
    Aaronson, SA
    [J]. ONCOGENE, 1999, 18 (18) : 2789 - 2797